Company Profile - VYNE Therapeutics Inc

Introduction

VYNE Therapeutics Inc (VYNE Therapeutics), is a late stage biopharmaceutical company. It is focused on the development and commercialization of serlopitant for the treatment of pruritus associated with dermatologic conditions such as psoriasis and prurigo nodularis, and for refractory chronic cough. The company's pipeline product candidate serlopitant, is a small molecule, highly selective NK1-R antagonist which reduces pruritus and refractory chronic cough symptoms. The company has licensing opportunities for development and commercialization of its pipeline product in all markets other than Japan. VYNE Therapeutics is headquartered in Redwood City, California, the US.